loader
Please Wait
Applying Filters...
menu
    • menu

    Setid A162fd5b B2ab 4d45 8861 71b60b92acb4 Applno 21351 Form Film Extended Release Transdermal Dosage 3 9mg 24hr - Drug Product Composition: 4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

    Menu

    4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 642Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21351 / DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OXYBUTYNIN(UNII: K9P6MC7092)
    (OXYBUTYNIN - UNII:K9P6MC7092)     		OXYBUTYNIN3.9mg in 1

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    TRIACETIN(XHX3C3X673)